一种新的nr2f1相关的微缺失可能导致Bosch-Boonstra-Schaaf视神经萎缩综合征。

IF 1.2 4区 医学 Q4 GENETICS & HEREDITY
Takaaki Hayashi, Kei Mizobuchi, Akiko Suga, Kazutoshi Yoshitake, Takeshi Iwata
{"title":"一种新的nr2f1相关的微缺失可能导致Bosch-Boonstra-Schaaf视神经萎缩综合征。","authors":"Takaaki Hayashi, Kei Mizobuchi, Akiko Suga, Kazutoshi Yoshitake, Takeshi Iwata","doi":"10.1080/13816810.2025.2522365","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Bosch-Boonstra-Schaaf optic atrophy syndrome (BBSOAS) is a rare autosomal dominant neurodevelopmental disorder that typically presents in early childhood. It is characterized by intellectual disability, developmental delay, and visual impairment, with optic atrophy being the most prominent ophthalmologic feature. The <i>nuclear receptor subfamily 2, group F, member 1</i> (<i>NR2F1</i>) gene is currently the only known causative gene associated with BBSOAS. To date, no cases of BBSOAS have been reported in the Japanese population.</p><p><strong>Cases presentation: </strong>We reported a 13-year-old Japanese male suspected of having BBSOAS, who presented with decreased visual acuity due to bilateral optic atrophy, as well as intellectual disability and developmental delay. Microarray-based comparative genomic hybridization (array-CGH), followed by whole-genome sequencing (WGS), identified a novel <i>de novo</i> 1.48-Mb heterozygous microdeletion involving <i>NR2F1</i>.</p><p><strong>Conclusions: </strong>This is the first reported case of BBSOAS in a Japanese patient. These findings highlight the utility of array-CGH and WGS as powerful tools for detecting <i>NR2F1</i>-related microdeletions. BBSOAS should be considered in the differential diagnosis of patients presenting with developmental delay, intellectual disability, and visual impairment, even in the absence of a family history.</p>","PeriodicalId":19594,"journal":{"name":"Ophthalmic Genetics","volume":" ","pages":"1-4"},"PeriodicalIF":1.2000,"publicationDate":"2025-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A novel <i>NR2F1</i>-associated microdeletion underlying Bosch-Boonstra-Schaaf optic atrophy syndrome.\",\"authors\":\"Takaaki Hayashi, Kei Mizobuchi, Akiko Suga, Kazutoshi Yoshitake, Takeshi Iwata\",\"doi\":\"10.1080/13816810.2025.2522365\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Bosch-Boonstra-Schaaf optic atrophy syndrome (BBSOAS) is a rare autosomal dominant neurodevelopmental disorder that typically presents in early childhood. It is characterized by intellectual disability, developmental delay, and visual impairment, with optic atrophy being the most prominent ophthalmologic feature. The <i>nuclear receptor subfamily 2, group F, member 1</i> (<i>NR2F1</i>) gene is currently the only known causative gene associated with BBSOAS. To date, no cases of BBSOAS have been reported in the Japanese population.</p><p><strong>Cases presentation: </strong>We reported a 13-year-old Japanese male suspected of having BBSOAS, who presented with decreased visual acuity due to bilateral optic atrophy, as well as intellectual disability and developmental delay. Microarray-based comparative genomic hybridization (array-CGH), followed by whole-genome sequencing (WGS), identified a novel <i>de novo</i> 1.48-Mb heterozygous microdeletion involving <i>NR2F1</i>.</p><p><strong>Conclusions: </strong>This is the first reported case of BBSOAS in a Japanese patient. These findings highlight the utility of array-CGH and WGS as powerful tools for detecting <i>NR2F1</i>-related microdeletions. BBSOAS should be considered in the differential diagnosis of patients presenting with developmental delay, intellectual disability, and visual impairment, even in the absence of a family history.</p>\",\"PeriodicalId\":19594,\"journal\":{\"name\":\"Ophthalmic Genetics\",\"volume\":\" \",\"pages\":\"1-4\"},\"PeriodicalIF\":1.2000,\"publicationDate\":\"2025-06-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Ophthalmic Genetics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1080/13816810.2025.2522365\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"GENETICS & HEREDITY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ophthalmic Genetics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/13816810.2025.2522365","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"GENETICS & HEREDITY","Score":null,"Total":0}
引用次数: 0

摘要

背景:Bosch-Boonstra-Schaaf视神经萎缩综合征(BBSOAS)是一种罕见的常染色体显性神经发育障碍,通常出现在儿童早期。它以智力障碍、发育迟缓和视力损害为特征,以视神经萎缩为最突出的眼科特征。核受体亚家族2,F组,成员1 (NR2F1)基因是目前唯一已知的与BBSOAS相关的致病基因。迄今为止,在日本人口中还没有报道过BBSOAS病例。病例介绍:我们报告了一名13岁的日本男性,怀疑患有BBSOAS,他表现为视力下降,由于双侧视神经萎缩,以及智力残疾和发育迟缓。基于微阵列的比较基因组杂交(array-CGH),随后进行全基因组测序(WGS),鉴定出一种新的涉及NR2F1的1.48 mb杂合微缺失。结论:这是日本患者首次报道的BBSOAS病例。这些发现强调了阵列- cgh和WGS作为检测nr2f1相关微缺失的强大工具的实用性。对于表现为发育迟缓、智力残疾和视力障碍的患者,即使没有家族史,也应考虑BBSOAS的鉴别诊断。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
A novel NR2F1-associated microdeletion underlying Bosch-Boonstra-Schaaf optic atrophy syndrome.

Background: Bosch-Boonstra-Schaaf optic atrophy syndrome (BBSOAS) is a rare autosomal dominant neurodevelopmental disorder that typically presents in early childhood. It is characterized by intellectual disability, developmental delay, and visual impairment, with optic atrophy being the most prominent ophthalmologic feature. The nuclear receptor subfamily 2, group F, member 1 (NR2F1) gene is currently the only known causative gene associated with BBSOAS. To date, no cases of BBSOAS have been reported in the Japanese population.

Cases presentation: We reported a 13-year-old Japanese male suspected of having BBSOAS, who presented with decreased visual acuity due to bilateral optic atrophy, as well as intellectual disability and developmental delay. Microarray-based comparative genomic hybridization (array-CGH), followed by whole-genome sequencing (WGS), identified a novel de novo 1.48-Mb heterozygous microdeletion involving NR2F1.

Conclusions: This is the first reported case of BBSOAS in a Japanese patient. These findings highlight the utility of array-CGH and WGS as powerful tools for detecting NR2F1-related microdeletions. BBSOAS should be considered in the differential diagnosis of patients presenting with developmental delay, intellectual disability, and visual impairment, even in the absence of a family history.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Ophthalmic Genetics
Ophthalmic Genetics 医学-眼科学
CiteScore
2.40
自引率
8.30%
发文量
126
审稿时长
>12 weeks
期刊介绍: Ophthalmic Genetics accepts original papers, review articles and short communications on the clinical and molecular genetic aspects of ocular diseases.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信